Ken Griffin 111, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	BUY	$0.61 - $1.19 $1,098 - $2,142	1,800 Added 12.33%	16,400 $10,000
Q3 2024 Nov 14, 2024	BUY	$0.56 - $1.23 $1,456 - $3,198	2,600 Added 21.67%	14,600 $11,000
Q2 2024 Aug 14, 2024	BUY	$0.97 - $1.34 $11,640 - $16,080	12,000 New	12,000 $12,000
Q4 2023 Feb 14, 2024	SELL	$1.39 - $2.6 $1,945 - $3,640	-1,400 Reduced 34.15%	2,700 $4,000
Q3 2023 Nov 14, 2023	BUY	$2.36 - $3.34 $9,440 - $13,360	4,000 Added 4000.0%	4,100 $10,000
Q2 2023 Aug 14, 2023	BUY	$2.44 - $2.92 $244 - $292	100 New	100 $0

Ticker YI
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 83,271,600
Market Cap $555M
Description
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultati...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.